The history of Viagra, initially marketed by copyright, presents a intricate case study for stakeholders considering the drug landscape . Although its early success and impact of vast in revenue , the intellectual property lapse has opened the floodgates for competing medications, greatly diminishing profit opportunities. This shift raises doubts a